Interleukin-6 as potential mediator of long-term neuropsychiatric symptoms of COVID-19

The majority of COVID-19 survivors experience long-term neuropsychiatric symptoms such as fatigue, sleeping difficulties, depression and anxiety. We propose that neuroimmune cross-talk via inflammatory cytokines such as interleukin-6 (IL-6) could underpin these long-term COVID-19 symptoms. This hypo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kappelmann, Nils, Dantzer, Robert, Khandaker, Golam M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172271/
https://www.ncbi.nlm.nih.gov/pubmed/34119855
http://dx.doi.org/10.1016/j.psyneuen.2021.105295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172271/
https://www.ncbi.nlm.nih.gov/pubmed/34119855
http://dx.doi.org/10.1016/j.psyneuen.2021.105295

Ejemplares similares